Summit Therapeutics shares owned by Guggenheim Capital, LLC Managers
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Guggenheim Capital, LLC Managers
from 13F filings
Historical chart of Guggenheim Capital, LLC Managers investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Guggenheim Capital, LLC Managers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Guggenheim Capital, LLC Managers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $847k | 41k | 20.66 |
| 2025-06-30 | $733k | 35k | 21.28 |
| 2025-03-31 | $784k | 41k | 19.29 |
| 2024-12-31 | $766k | 43k | 17.85 |
More positions owned by Guggenheim Capital, LLC Managers
View all positions for Guggenheim Capital, LLC Managers